Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular CarcinomaLaia Bassaganyas, Roser Pinyol, Roger Esteban-Fabró, et al.British Journal of Cancer|July 10, 2019
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trialsRobert Montal, Carmen Andreu-Oller, Laia Bassaganyas, et al.Journal of Hepatology|January 28, 2017
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entityAgrin Moeini, Daniela Sia, Zhongyang Zhang, et al.Journal of Hepatology|January 30, 2017
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCCRiccardo Lencioni, Robert Montal, Ferran Torres, et al.Journal for Immunotherapy of Cancer|March 18, 2025
Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapiesJoel Veas Rodriguez, Miquel Piñol, Maria Alba Sorolla, et al.Molecular Cancer Therapeutics|April 3, 2016
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR TherapiesDaniel Azuara, Cristina Santos, Adriana Lopez-Doriga, et al.Cancer Treatment Reviews|April 26, 2026
Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHTMario Balsa, Sergio Alonso, Laura Sánchez, et al.Molecular Cancer|May 12, 2023
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancerVanessa Ortiz-Barahona, Marta Soler, Veronica Davalos, et al.Journal of Hepatology|March 17, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Daniela Sia, Carla Montironi, et al.Gut|August 16, 2018
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trialRoser Pinyol, Robert Montal, Laia Bassaganyas, et al.Pageof 3